The evaluation of the effect of trace metals on health can be difficult, because of their presence in the environment in various chemical forms. Exposure to arsenic compounds is an example of this complexity, as it can be present in the environment in inorganic and organic forms. The effects of arsenic in vertebrates are complicated by several variables, such as speciation of the element, the exposure route, and the susceptibility of the particular animal species. The embryotoxicity and teratogenicity of three arsenic species — sodium arsenite (NaAsO2), disodium hydrogen arsenate (Na2HAsO4) and dimethylarsinic acid [(CH3)2AsOOH] — were evaluated by the modified frog embryo teratogenic assay on Xenopus (FETAX). We also show how the classical FETAX endpoints, based on morphological and morphometrical analysis, can conveniently be integrated with the study of molecular markers. Possible changes in the expression of the mRNA for the heat-shock protein HSP70, following exposure to NaAsO2, were examined by using the reverse transcriptase polymerase chain reaction. HSP70 mRNA is strongly induced by arsenic.
CantorK.P. (2001). Invited commentary: arsenic and cancer of the urinary tract. American Journal of Epidemiology153, 422–423.
5.
CohenS.M., YamamotoS., CanoM., & ArnoldL.L. (2001). Urothelial cytotoxicity and regeneration induced by dimethylarsinic acid in rats. Toxicological Sciences59, 68–74.
6.
YihL.H., & LeeT.C. (2000). Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts. Cancer Research60, 6346–6352.
7.
SimenovaP.P., & LusterM.I. (2000). Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanism?Journal of Environmental Pathology, Toxicology and Oncology19, 281–286.
8.
GleyzesC., TellierS., SabrierR., & AstrucM. (2001). Arsenic characterisation in industrial soils by chemical extractions. Environmental Technology22, 27–38.
9.
SmithA.H., LigasE.O., & RahmanM. (2000). Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bulletin of the World Health Organization78, 1093–1103.
10.
RayB. (1975). Fate of organic arsenicals in soils and plants. International Pest Control17, 9–14.
11.
MayerD.R., KosmusW., PogglitshH., MayerD., & BayerW. (1993). Essential trace elements in humans. Serum arsenic concentrations in hemodialysis patients in comparison to healthy controls. Biological Trace Element Research37, 27–38.
12.
TabacovaS., HunterE.S., & GladenB.C. (1996). Developmental toxicity of inorganic arsenic in whole embryo culture: oxidation state, dose, time, and gestational age dependence. Toxicology and Applied Pharmacology138, 298–307.
13.
OyaohtaY., KaiseT., & OchiT. (1996). Induction of chromosomal aberration in cultured fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction. Mutation Research – Fundamental and Molecular Mechanisms of Mutagenesis357, 123–129.
14.
SabbioniE., FischbachM., PozziG., PietraR., GalloriniM., & PietteJ.L. (1991). Cellular retention, toxicity and carcinogenic potential of seafood arsenic. I. Lack of cytotoxicity and transforming activity of arsenobetaine in the BALB/3T3 cell line. Carcinogenesis12, 1287–1291.
15.
BorgonoJ.M., VincentP., VentrinoH., & InfanteA. (1977). Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of a treatment plant. Environmental Health Perspectives19, 103–105.
16.
SagerP.R., ClarksonT.W., & NordbergG.F. (1986). In Handbook of the Toxicology of Metals, Vol I (ed. FribergL., NordbergG.F., & VoukV.B.), pp. 414–415. Amsterdam, The Netherlands: Elsevier.
17.
LeonardA., & LauwerysR. (1980). Teratogenicity and mutagenicity of arsenic. Mutation Research75, 49–62.
18.
HanlonD.P., & FermV.H. (1986). Concentration and chemical status of arsenic in the blood of pregnant hamsters during critical embryogenesis. 1. Subchronic exposure to arsenate using constant rate administration. Environmental Research40, 372–379.
19.
Environmental Protection Agency (1980). Ambient water quality criteria for arsenic, U.S. Environmental Protection Agency Report, 440/5–80–021, pp. 1–205. Research Triangle Park, NC, USA: EPA.
20.
DesessoJ.M., JacobsonC.F., ScialliA.R., FarrC.H., & HolsonJ.F. (1998). An assessment of the developmental toxicity of inorganic arsenic. Reproductive Toxicology12, 385–433.
21.
GolubM.S., MacintoshM.S., & BaumrindN. (1998). Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. Journal of Toxicology and Environmental Heath1, 199–241.
22.
NemecM.D., HolsonJ.F., FarrC.H., & HoodR.D. (1998). Developmental toxicity assessment of arsenic acid in mice and rabbits. Reproductive Toxicology12, 647–658.
23.
HolsonJ.F., DesessoJ.M., JacobsonC.F., & FarrC.H. (2000). Appropriate use of animal models in the assessment of risk during prenatal development: an illustration using inorganical arsenic. Teratology62, 51–71.
24.
SpielmannH. (1998). Reproduction and development. Environmental Health Perspectives106, 571–576.
25.
SabbioniE., BallsM., PietraR., & FortanerS. (1999). The IMETOX project (In vitro MEtal TOXicology). ATLA27, Suppl. 1, 107.
26.
PratiM., GornatiR., BoracchiP., BiganzoliE., FortanerS., PietraR., SabbioniE., & BernardiniG. (2002). A study of the toxicity of mercury dichlo-ride and methylmercury, assayed by the frog embryo teratogenesis assay — Xenopus (FETAX). ATLA30, 23–32.
27.
BallsM., BlaauboerB.J., FentemJ., BrunerL., CombesR.D., EkwallB., FriedlerR.J., GuillouzoA., LewisR.W., LovellD.P., ReinhardtC.A., RepettoG., SladowskiD., SpielmannH., & ZuccoF. (1995). Practical aspects of the validation of toxicity tests procedures. The report and recommendations of ECVAM workshop 5. ATLA23, 129–143.
28.
FortD.J., StoverE.L., BantleJ.A., RayburnJ.R., HullM., FinchR.A., BurtonD.T., TurleyS.D., DawsonD.A., LinderG., BuchwalterD., DumontJ.N., Kumsher-KingM., & Gaudet-HullA.M. (1998). Phase III interlaboratory study of FETAX. Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay — Xenopus (FETAX). Drug and Chemical Toxicology21, 1–14.
29.
BernardiniG., SpinelliO., PresuttiC., VismaraC., BolzacchiniE., OrlandiM., & SettimiR. (1996). Evaluation of the developmental toxicity of the pesticide MCPA and its contaminants phenol and chlorocresol. Environmental Toxicology and Chemistry15, 754–760.
30.
BernardiniG., AndriettiF., CamantiniM., & CossonM.P. (1988). Xenopus spermatozoon: correlation between shape and motility. Gamete Research20, 165–175.
31.
SakumaM. (1998). Probit analysis of preference data. Applied Entomology and Zoology33, 339–347.
32.
DawsonDA., & BantleJA. (1987). Development of a reconstituted water medium and preliminary validation of the frog embryo teratogenesis assay — Xenopus (FETAX). Journal of Applied Toxicology7, 237–244.
LeeY.J., CurettyL., & CorryP.M. (1991). Differences in preferential synthesis and redistribution of HSP70 and HSP28 families by heat or sodium arsenite in Chinese hamster ovary cells. Journal of Cellular Physiology149, 77–87.
35.
DeatonM.A., BowmanP.D., JonesG.P., & PowandaM.C. (1990). Stress protein synthesis in human keratinocytes treated with sodium arsenite, phenyldichloroarsine, and nitrogen mustard. Fundamental and Applied Toxicology14, 471–476.
36.
DaraschS., MosserD.D., BolsN.C., & HeikkilaJ.J. (1988). Heat shock gene expression in Xenopus laevis A6 cells in response to heat shock and sodium arsenite treatments. Biochemistry and Cell Biology66, 862–870.
37.
TedeschiG., NegriA., BernardiniG., OungreE., CecilianiF., & RonchiS. (1999). D-Aspartate oxidase is present in ovaries, eggs and embryos but not in testis of Xenopus laevis.Comparative Biochemistry and Physiology B — Biochemistry and Molecular Biology124, 489–494.
38.
RizzoA.M., RossiF., GuerraA., BerraB., GornatiR., BernardiniG., & SonninoS. (2001). Exogenous sphingosine enters Xenopus laevis embryos grown in Petri dishes and it is metabolised. Bioscence Report21, 719–731.
